3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
19
Myeloproliferative Disorders
16
Polycythemia Vera
10
Leukemia
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
6
Pancreatic Neoplasms
5
Myelodysplastic Syndromes
5
Hematologic Diseases
5
Thrombocythemia, Essential
4
Multiple Myeloma
4
Bone Marrow Diseases
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Graft vs Host Disease
3
Thrombocytosis
2
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Bronchiolitis Obliterans Syndrome
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Preleukemia
1
Precancerous Conditions
1
Pathologic Complete Response
1
Interventions
fludarabine phosphate
23
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
18
Mycophenolic Acid
16
Cyclophosphamide
15
Busulfan
15
Tacrolimus
14
Antilymphocyte Serum
14
Cyclosporine
11
Melphalan
10
Rituximab
9
Methotrexate
9
Etoposide
8
romidepsin
6
Flow Cytometry
6
Filgrastim
6
Vorinostat
5
Dexamethasone
5
thymoglobulin
4
fludarabine
4
Sirolimus
4
Granulocyte Colony-Stimulating Factor
4
Carboplatin
4
Calcium Dobesilate
4
Bexarotene
4
Alemtuzumab
4
Thiotepa
3
Therapeutics
3
Radiotherapy
3
Panobinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Cutaneous
×
ruxolitinib
×
Clear all
No trials found.